American Healthcare REIT, Inc. (AHR)
NYSE: AHR · IEX Real-Time Price · USD
15.13
+0.37 (2.51%)
Jul 2, 2024, 4:00 PM EDT - Market closed
American Healthcare REIT Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for AHR stock have an average target of 16.14, with a low estimate of 14 and a high estimate of 18. The average target predicts an increase of 6.68% from the current stock price of 15.13.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AHR stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 |
| Buy | 5 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Reiterates $16 → $17 | Strong Buy | Reiterates | $16 → $17 | +12.36% | Jul 1, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $16 | Buy | Reiterates | $16 | +5.75% | May 16, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $17 → $16 | Strong Buy | Maintains | $17 → $16 | +5.75% | Apr 3, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +12.36% | Mar 25, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $16 | Buy | Reiterates | $16 | +5.75% | Mar 25, 2024 |
Financial Forecast
Revenue This Year
2.01B
from 1.87B
Increased by 7.73%
Revenue Next Year
2.10B
from 2.01B
Increased by 4.23%
EPS This Year
0.32
from -1.08
EPS Next Year
0.48
from 0.32
Increased by 50.00%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 2.2B | 2.3B | 2.4B |
| Avg | 2.0B | 2.1B | 2.2B |
| Low | 1.6B | 1.8B | 1.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 18.4% | 12.2% | 12.3% |
| Avg | 7.7% | 4.2% | 3.0% |
| Low | -12.0% | -11.6% | -9.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.28 | 1.41 | 0.36 |
| Avg | 0.32 | 0.48 | 0.34 |
| Low | 0.02 | 0.17 | 0.33 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 335.3% | -26.4% |
| Avg | - | 50.0% | -29.2% |
| Low | - | -48.5% | -31.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.